Pharmafile Logo
Pharmafocus logo
Advanced Search

Talking Point: The future for pharmaceutical delivery

February 26, 2010
Manufacturing and Production Polar Speed, Talking Point, logistics, supply chain, talking logistics

Will the future for pharmaceutical delivery need to become more exacting and regulated? An ever greater awareness of the need …

Feature

Quotient Clinical receives MHRA Supplementary Accreditation

February 26, 2010
Research and Development Quotient

 This is one of the highest levels of accreditation in Europe and confirms that Quotient Clinical is qualified to perform …

Feature
Case study
Press release

Government ups the ante in dementia research

February 26, 2010
Research and Development Alzheimer's, dementia

The government has attempted to ‘up the ante’ in dementia research by convening a ministerial group comprising charities, scientists, research …

News

Nick Workman joins A La Carte

February 26, 2010
Business Services A La Carte, appointment, business services

Life sciences recruitment search consultancy A La Carte has appointed Nick Workman as international director. In his new role he …

Appointment

Olivia Wilmshurst-Smith joins Woolley Pau

February 26, 2010
Medical Communications Woolley Pau, appointment, medical communications

Advertising agency Woolley Pau has appointed Olivia Wilmshurst-Smith as an account executive. She is a keen linguist and recently graduated …

Appointment

GSK hits back at Avandia safety probe

February 25, 2010
Sales and Marketing Avandia, diabetes

GlaxoSmithKline has hit back at allegations from US Senators that its diabetes drug Avandia raises the risk of heart attacks, …

News
Blog footer

Digital Pharma: Novartis tells cystic fibrosis stories

February 25, 2010
Medical Communications Novartis, cystic fibrosis, digi, digi pharma, social media

Novartis has launched a new disease awareness campaign for cystic fibrosis that blurs the lines between fact and fiction. Its …

News

Avastin study in ovarian cancer meets primary endpoint

February 25, 2010
Research and Development Cancer, avastin, ovarian

Preliminary results from a trial of Roche’s Avastin in advanced ovarian cancer suggest that the drug lengthens progression-free survival when …

News

Sanofi’s breast cancer candidate tipped for future success

February 25, 2010
Research and Development, Sales and Marketing BSI-201, Sanofi-Aventis, breast cancer

A Sanofi-Aventis drug currently in phase III has been predicted as a future blockbuster in breast cancer treatment. Sanofi’s BSI-201 …

News
DConnelly

GSK’s Deidre Connelly named Woman of the Year

February 25, 2010
Sales and Marketing GlaxoSmithKline, HBA, appointment, sales and marketing

The Healthcare Businesswomen’s Association has named Deidre Connelly its 2010 Woman of the Year. Connelly is president of North America …

Appointment

CME Spotlight: Restoring confidence

February 25, 2010
Medical Communications CME, CME Spotlight, Eugene Pozniak, ethics

As John Maynard Keynes said: “The long term doesn’t matter very much, because in the long run, we are all …

Feature

New starters at Double Helix

February 25, 2010
Sales and Marketing Double Helix, appointment, sales and marketing

Healthcare consultancy Double Helix has appointed Amanda Siebols (pictured) as a research consultant and Ioanna Maraki as a research executive. …

Appointment
President Obama

Obama ‘closer than ever’ to health reform

February 25, 2010
Sales and Marketing Obama, US healthcare

The continuing showdown over health insurance reform in the US reaches its next potential flashpoint today (Thursday) with what is …

News

Merck KGaA posts modest revenue increase

February 24, 2010
2009 financials, Erbitux, Merck KGaA, Merck Serono, Rebif

German pharma company Merck has posted a modest rise in revenue amidst strong pharma growth.  Revenues increased 2.1% to 7.7 …

News

Sudler & Hennessey promotes Max Jackson

February 24, 2010
Medical Communications Sudler & Hennessey, appointment, medical communications

Max Jackson has been promoted to chief executive, EMEA and APAC, at advertising agency Sudler & Hennessey (S&H). In his …

Appointment

Avastin fails in phase III study

February 24, 2010
Research and Development Roche, avastin, gastric cancer, stomach cancer

Roche’s Avastin does not help patients with a severe form of stomach cancer to live longer, according to the results …

News

NICE approves Yondelis

February 24, 2010
Sales and Marketing NICE, PharmaMar, Yondelis

Cancer drug Yondelis has been approved by NICE for use on the NHS, but only after the manufacturer offered to …

News

NHS Alliance finds its own third way

February 24, 2010
NHS, NHS Alliance

The NHS Alliance has proposed a new business model for the NHS that would draw on the health service’s founding …

News

Methylene blue poised to move into the clinic

February 24, 2010
Manufacturing and Production, Research and Development Novasep, ProveBlue, Provepharm, malaria

A new purer form of the reagent methylene blue could take the compound out of the testing laboratory and into …

News
McCannAndrewBerrie

New role for McCann’s Andrew Berrie

February 24, 2010
Medical Communications McCann Healthcare, appointment, medical communications

Andrew Berrie’s roll within McCann Healthcare Worldwide’s Medical Communications arm has been enlarged.  His remit will now also include being …

Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025